Skip to main content

Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis.

Publication ,  Journal Article
Liao, SM; Goldschmidt-Clermont, PJ; Sugarman, J; Working Group on Ethics of Progenitor Cell-based Strategies for Disease Prevention,
Published in: J Med Ethics
November 2007

OBJECTIVE: To examine important ethical and societal issues relating to the use of progenitor-cell-based strategies for disease prevention, particularly atherosclerosis. BACKGROUND: Several nascent lines of evidence suggest the feasibility of using progenitor cells to reverse the health consequence of atherosclerosis. Such potential uses of progenitor cells are scientifically exciting, yet they raise important ethical and societal issues. METHOD: The Working Group on Ethics of Progenitor Cell-based Strategies for Disease Prevention met to discuss the relevant issues. Several drafts of a report were then circulated to the entire Working Group for comments until a consensus was reached. RESULTS: Scientific evidence suggests the appropriateness of using progenitor-cell-based strategies for some rare conditions involving atherosclerosis, but additional preclinical data are needed for other, more prevalent conditions before human trials begin. All such trials raise a set of ethical issues, especially since trials aimed at prevention rather than treatment may involve persons who do not yet have disease but will be exposed to the risks of interventions. In addition, enrolment in prevention trials may be hazardous and harmful if participants erroneously believe experimental interventions will necessarily prevent disease. Finally, given the high prevalence of atherosclerosis, there are some important public policy implications of taking such an approach to prevention, including the sources of progenitor cells for such interventions as well as the allocation of health resources. CONCLUSION: Potential uses of progenitor-cell-based strategies for preventing atherosclerosis must be considered in the context of a range of social and ethical issues.

Duke Scholars

Published In

J Med Ethics

DOI

ISSN

0306-6800

Publication Date

November 2007

Volume

33

Issue

11

Start / End Page

643 / 646

Location

England

Related Subject Headings

  • Stem Cells
  • Humans
  • Health Policy
  • Ethics, Clinical
  • Biomedical Research
  • Atherosclerosis
  • Applied Ethics
  • 5001 Applied ethics
  • 2201 Applied Ethics
  • 1801 Law
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liao, S. M., Goldschmidt-Clermont, P. J., Sugarman, J., & Working Group on Ethics of Progenitor Cell-based Strategies for Disease Prevention, . (2007). Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J Med Ethics, 33(11), 643–646. https://doi.org/10.1136/jme.2006.017251
Liao, S Matthew, Pascal J. Goldschmidt-Clermont, Jeremy Sugarman, and Jeremy Working Group on Ethics of Progenitor Cell-based Strategies for Disease Prevention. “Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis.J Med Ethics 33, no. 11 (November 2007): 643–46. https://doi.org/10.1136/jme.2006.017251.
Liao SM, Goldschmidt-Clermont PJ, Sugarman J, Working Group on Ethics of Progenitor Cell-based Strategies for Disease Prevention. Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J Med Ethics. 2007 Nov;33(11):643–6.
Liao, S. Matthew, et al. “Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis.J Med Ethics, vol. 33, no. 11, Nov. 2007, pp. 643–46. Pubmed, doi:10.1136/jme.2006.017251.
Liao SM, Goldschmidt-Clermont PJ, Sugarman J, Working Group on Ethics of Progenitor Cell-based Strategies for Disease Prevention. Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J Med Ethics. 2007 Nov;33(11):643–646.

Published In

J Med Ethics

DOI

ISSN

0306-6800

Publication Date

November 2007

Volume

33

Issue

11

Start / End Page

643 / 646

Location

England

Related Subject Headings

  • Stem Cells
  • Humans
  • Health Policy
  • Ethics, Clinical
  • Biomedical Research
  • Atherosclerosis
  • Applied Ethics
  • 5001 Applied ethics
  • 2201 Applied Ethics
  • 1801 Law